More Americans will have medical devices deployed in vessels near their brains to fish out debilitating blood clots thanks to changes in the national guidelines for treating stroke patients.
The new guidelines, announced Monday by the American Heart Association (AHA), recommend that patients with the worst kinds of strokes be treated with medical devices like one designed in Minnesota to break up blood clots. The devices are used in combination with clot-busting drugs.
It's the first time that consensus guidelines for stroke recommend using a medical device to remove a clot that kills brain cells by cutting off blood supply. It follows half a dozen studies in recent years that sought to measure the benefit of using devices along with drugs, rather than drugs alone.
The change is intended to improve stroke survival rates while cutting the percentage of patients who emerge from the hospital debilitated because a clot has caused permanent brain damage. Strokes are the No. 5 cause of death in the U.S., but the top cause of disability.
"If you can get someone back to functional independence who was going to be debilitated and reliant on a caregiver … that is a huge win across the board," said Brett Wall, president of Medtronic's Neurovascular division, which makes a clot-removal device.
Only two so-called stent retriever devices are approved in the United States: Medtronic's Solitaire, which was originally designed by Plymouth firm ev3; and the Trevo ProVue Retriver, made by Michigan-based Stryker Corp.
"There is now overwhelming evidence that treatment of the largest, most devastating type of stroke requires emergent endovascular intervention in addition to" clot-busting drugs, North Carolina stroke specialist Dr. Donald Heck said Monday in news release distributed by Stryker.
However, access to the best stroke care remains a challenge.